LT2078B - Izochinolino dariniu gavimo budas - Google Patents

Izochinolino dariniu gavimo budas

Info

Publication number
LT2078B
LT2078B LTRP478A LTRP478A LT2078B LT 2078 B LT2078 B LT 2078B LT RP478 A LTRP478 A LT RP478A LT RP478 A LTRP478 A LT RP478A LT 2078 B LT2078 B LT 2078B
Authority
LT
Lithuania
Prior art keywords
isochinolin
receiving budget
dental receiving
dental
budget
Prior art date
Application number
LTRP478A
Other languages
English (en)
Lithuanian (lt)
Inventor
Roy Archibald Swaringen Jr
Hassan Ali El-Sayad
David Arthur Yeowell
John Joseph Savarese
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of LT2078B publication Critical patent/LT2078B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Jib Cranes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
LTRP478A 1984-07-18 1993-04-07 Izochinolino dariniu gavimo budas LT2078B (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds
SU853926201A SU1468414A3 (ru) 1984-07-18 1985-07-17 Способ получени производных изохинолини

Publications (1)

Publication Number Publication Date
LT2078B true LT2078B (lt) 1993-06-15

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
LTRP478A LT2078B (lt) 1984-07-18 1993-04-07 Izochinolino dariniu gavimo budas

Country Status (30)

Country Link
US (1) US4761418A (de)
EP (1) EP0181055B1 (de)
JP (1) JPH0662568B2 (de)
AT (1) ATE60759T1 (de)
AU (1) AU574481B2 (de)
BG (1) BG60411B2 (de)
CA (1) CA1273341A (de)
CY (1) CY1687A (de)
DD (1) DD235638A5 (de)
DE (2) DE19675039I2 (de)
DK (1) DK168093B1 (de)
ES (1) ES8609260A1 (de)
FI (1) FI85019C (de)
GB (1) GB8418303D0 (de)
GE (1) GEP19960468B (de)
HK (1) HK47593A (de)
HU (1) HU193996B (de)
IE (1) IE58138B1 (de)
IL (1) IL75833A (de)
LT (1) LT2078B (de)
LU (1) LU88801I2 (de)
LV (1) LV5483A3 (de)
MC (1) MC1690A1 (de)
MX (1) MX9203667A (de)
NL (1) NL940023I2 (de)
NZ (1) NZ212766A (de)
PL (1) PL146066B1 (de)
SG (1) SG3493G (de)
SU (1) SU1468414A3 (de)
ZA (1) ZA855407B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
BR9808422B1 (pt) * 1997-03-25 2010-08-24 composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
EP1684753A2 (de) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuskuläre blockiermittel und ihre antagonisten
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
ATE554769T1 (de) * 2006-12-06 2012-05-15 Cornell Res Foundation Inc Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
WO2008107887A2 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2008117271A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2008132748A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
US8357805B2 (en) * 2007-06-18 2013-01-22 Chemagis Ltd. (1R,1′R)-atracurium salts separation process
CA2692636A1 (en) * 2007-07-09 2009-01-15 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
CA2702535A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel r,r'-atracurium salts
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
JP6236077B2 (ja) 2012-06-29 2017-11-22 コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法
CN116410078B (zh) * 2021-12-29 2026-04-03 苏州特瑞药业股份有限公司 一种制备(e)-辛-4-烯-1,8-二酸的方法
WO2025140288A1 (zh) * 2023-12-25 2025-07-03 上海森辉医药有限公司 一种四氢异喹啉及其药物用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
SU862820A3 (ru) * 1977-08-01 1981-09-07 Дзе Массачусетс Дженерал Хоспитал (Фирма) Способ получени производных изохинолини
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (en) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
EP0054309B1 (de) * 1980-12-17 1984-08-22 The Wellcome Foundation Limited Neuromuskuläre Blocker mit langer Wirkung, pharmazeutische Zubereitungen, die sie enthalten, und Verfahren zu ihrer Herstellung
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
FI852807L (fi) 1986-01-19
HK47593A (en) 1993-05-21
US4761418A (en) 1988-08-02
HUT40626A (en) 1987-01-28
BG60411B2 (bg) 1995-02-28
LV5483A3 (lv) 1994-03-10
PL146066B1 (en) 1988-12-31
AU574481B2 (en) 1988-07-07
HU193996B (en) 1987-12-28
FI852807A0 (fi) 1985-07-17
FI85019C (fi) 1992-02-25
NZ212766A (en) 1988-03-30
GB8418303D0 (en) 1984-08-22
CY1687A (en) 1993-10-10
IE58138B1 (en) 1993-07-14
SU1468414A3 (ru) 1989-03-23
JPS6187666A (ja) 1986-05-06
PL254571A1 (en) 1986-07-15
MX9203667A (es) 1992-07-31
JPH0662568B2 (ja) 1994-08-17
ATE60759T1 (de) 1991-02-15
ES8609260A1 (es) 1986-09-01
GEP19960468B (en) 1996-08-29
AU4510885A (en) 1986-01-23
NL940023I1 (nl) 1995-01-02
MC1690A1 (fr) 1986-07-18
DK168093B1 (da) 1994-02-07
DK324985D0 (da) 1985-07-17
DD235638A5 (de) 1986-05-14
NL940023I2 (nl) 1998-06-02
CA1273341A (en) 1990-08-28
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
EP0181055A1 (de) 1986-05-14
ZA855407B (en) 1986-04-30
IE851791L (en) 1986-01-18
DK324985A (da) 1986-01-19
EP0181055B1 (de) 1991-02-06
IL75833A0 (en) 1985-11-29
SG3493G (en) 1993-03-12
LU88801I2 (fr) 1996-11-05
FI85019B (fi) 1991-11-15
DE3581699D1 (de) 1991-03-14
DE19675039I2 (de) 2003-01-09

Similar Documents

Publication Publication Date Title
LT2078B (lt) Izochinolino dariniu gavimo budas
ZA857270B (en) Tetralin derivatives,their preparation and their use
ZA862289B (en) Application of azolylmethyloxiranes for the treatmazolylmethyloxiranes,their preparation and their uent of viral diseases se as crop protection agents
ES538757A0 (es) Procedimiento para la preparacion de 11b-aril-estradienos
EA199900756A1 (ru) Замещенные изохинолины в качестве нервно-мышечных блокаторов ультракраткосрочного действия
NZ208831A (en) Imidazolium derivatives and pharmaceutical compositions
FR2642642B1 (fr) Implant d'osteosynthese posterieure rachidienne
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
DE3785046A1 (de)
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
ZA90962B (en) Phenylhydrazones,the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
PH21941A (en) Difluorocyclopropane derivatives,pesticidal compositions based on these compounds and method of use thereof
IE860987L (en) Triazole derivatives
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.
DK159184A (da) Pterinforbindelser
IT1276751B1 (it) Composti ad attivita' antitumorale

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20000717